FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 175 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $766,000 | +629.5% | 20,329 | -10.9% | 0.01% | +400.0% |
| Q4 2019 | $105,000 | +144.2% | 22,818 | +106.4% | 0.00% | +100.0% |
| Q3 2019 | $43,000 | -88.4% | 11,054 | -82.1% | 0.00% | -85.7% |
| Q2 2019 | $372,000 | +156.6% | 61,664 | +468.7% | 0.01% | +40.0% |
| Q1 2019 | $145,000 | -59.2% | 10,843 | -71.6% | 0.01% | -70.6% |
| Q4 2018 | $355,000 | +84.9% | 38,151 | +241.8% | 0.02% | +54.5% |
| Q1 2018 | $192,000 | -10.7% | 11,163 | +13.8% | 0.01% | 0.0% |
| Q4 2017 | $215,000 | +593.5% | 9,808 | +1211.2% | 0.01% | +450.0% |
| Q3 2017 | $31,000 | -72.3% | 748 | -76.0% | 0.00% | -75.0% |
| Q1 2017 | $112,000 | -70.1% | 3,111 | -56.4% | 0.01% | -66.7% |
| Q3 2016 | $375,000 | +109.5% | 7,142 | +64.9% | 0.02% | +140.0% |
| Q2 2016 | $179,000 | -47.4% | 4,331 | -48.3% | 0.01% | -47.4% |
| Q1 2016 | $340,000 | +67.5% | 8,372 | +71.4% | 0.02% | +58.3% |
| Q4 2015 | $203,000 | +712.0% | 4,885 | +203.2% | 0.01% | +1100.0% |
| Q3 2015 | $25,000 | -64.3% | 1,611 | -42.5% | 0.00% | -66.7% |
| Q2 2015 | $70,000 | -73.1% | 2,800 | -71.0% | 0.00% | -78.6% |
| Q4 2014 | $260,000 | – | 9,647 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |